Europe Immunodiagnostic Market Analysis report provides a granular strategic analysis of over 100 clinical chemistries, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both centralized (hospitals, commercial laboratories), and POC/decentralized locations. The report explores future market trends; forecasts specimen, test, and sales volume; estimates sales and market shares of key suppliers in major countries; compares features of leading analyzers; profiles key competitors; and identifies specific product and marketing opportunities for reagent and instrument suppliers.
This new 31-country report is available by country, market segment, section, or individual test.

Clinical chemistry and immunodiagnostic markets are undergoing significant transformation, caused by a convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments, like routine chemistry, are already resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace creates exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, and calibrators.

Country Analyses

Denmark
France
Germany
Greece
Italy
Netherlands
Spain
Switzerland
UK

Global Market Overview

- Estimates of facilities performing clinical chemistry and immunodiagnostic tests in major countries.

- Test volume and sales projections.

Market Segmentation Analysis

- A comprehensive review of the market dynamics, trends, structure, size, growth, and key suppliers.

- Test volume and sales forecasts for over 100 clinical chemistries, TDM, endocrine, cancer, immunoprotein, and abused drug assays.

Individual Tests Analyzed in the Report

Clinical Chemistry

Therapeutic Drug Monitoring (TDM)

Endocrine Function

Tumor Markers and Special Chemistry

Immunoproteins

Drugs of Abuse

Current and Emerging Products

 Analysis of current and emerging clinical chemistry and immunodiagnostic tests.

 Review of current instrumentation technologies, and feature comparison of high-, medium-, and low-volume/POC analyzers.

Technology Review

 Assessment of current and emerging technologies, and their potential market applications.

 Companies developing or marketing new technologies and products by test.

Strategic Recommendations

 New product development opportunities with significant market appeal.

 Alternative market penetration strategies.

 Potential market entry barriers and risks.

Competitive Assessments

 Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

    Abbott
    AdnaGen
    Agilent Technologies
    Bayer Healthcare
    Beckman Coulter/Danaher
    Biomedical Diagnostics
    Sysmex
    Thermo Fisher/Affymetrix
    Tosoh
    Wako
    Wallac/PE

Category: Healthcare Market Research

Contact Details:

Aarkstore Enterprise

+917710006788 | contact@aarkstore.com | aarkstore.com